Learn More
Medchemexpress LLC NBI-31772 | 374620-70-9 | 98.9% | 341.27 | 100 MG

Supplier: Medchemexpress LLC HY11013550MG
NBI-31772 is a non-selective IGFBP inhibitor with a Ki of 47 nM. It exhibits neuroprotective effects, reducing infarct volume during cerebral ischemia. It can also restore or enhance proteoglycan synthesis in osteoarticular chondrocytes and increases the effect of IGF3 on zebrafish oocyte maturation.
- Stimulates the synthesis of IGF-1-dependent proteoglycans in human OA chondrocytes.
- Significantly stimulates the percentage of rabbit articular chondrocyte-associated proteoglycans.
- Dose-dependently induces the maturation of zebrafish oocytes.
- Reduces total infarct volume and cortical infarct volume in rats with middle cerebral artery occlusion (MCAO) model.
- Reduces cortical infarct size and brain swelling in rats with intraluminal suture MCAO model.
- Induces germinal vesicle rupture in zebrafish.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.